REG - Oxford Biomedica PLC - Director/PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>

Oxford BioMedicaAnnouncement

05/09/2017 11:45

RNS Number : 8627P
Oxford Biomedica PLC
05 September 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1
Issuer
Oxford BioMedica PLC
2
Reason for notification
Notification relates to DTR 3.1.2R
3
Name of PDMR
Martin Diggle
4
Connected person
Notification relates to following connected persons:
Vulpes Testudo Fund
5
Notification in respect of
Notification in respect of holdings of persons in 4 above
6
Description of shares
Oxford BioMedica PLC ordinary shares of 1p each
7
Name of registered shareholders and number of shares
Vulpes Life Sciences Fund - 549,932,000 shares
Vulpes Testudo Fund - 33,334,434 shares
8
Nature of transaction
Disposal 
9
Number of shares acquired
N/A
10
Percentage of issued class acquired
N/A
11
Shares disposed
Vulpes Testudo Fund - 2,377,600
12
Percentage of issued class disposed
Vulpes Testudo Fund - 0.08%
13/14
Price per share of transactions, and date
Vulpes Testudo Fund 
Sold 2,377,600 shares @ 0.1009, 31 Aug 2017
15
Total holding following notification and total percentage holding following notification
Vulpes Life Sciences Fund - 549,932,000 shares
17.7%
Vulpes Testudo Fund - 30,956,834 shares
1.0%
16
Date issuer informed
05 Sept 2017



23
Any additional information
None
24
Contact name and telephone number
S. Paynter, Chief Financial Officer
Oxford BioMedica
+44 (0)1865 783000

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBGGDCBSGBGRU